CHORIONIC GONADOTROPIN, 4000 Units, sterile powder for reconstitution, glass vial, RX, Creative Compounds, Wilsonville, OR 97070
Published November 12, 2014 · Recall initiated: October 6, 2014
Summary
FDA records drug Class II recall D-0181-2015, published November 12, 2014 and initiated October 6, 2014. Recalling firm: Oregon Compounding Centers, Inc. dba Creative Compounds; Status: Terminated; Reported quantity: 145 vials; Lot: Lot #: 20140728@55, discard date: 1/14/2015; Lot #: 20140915@14, discard date: 3/8/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Oregon Compounding Centers, Inc. dba Creative Compounds
- Distributor
- Oregon, Washington
- Lot
- Lot #: 20140728@55, discard date: 1/14/2015; Lot #: 20140915@14, discard date: 3/8/2015.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACEFTAZIDIME, 2.25mg/0.1mL, Injectable, 0.2 mL plastic syringe, RX, Creative Compounds, Wilsonville, OR 97070November 12, 2014
- FDAPAPAVERINE/PHENTOLAMINE/PROSTAGLANDIN, 17.64mg/0.58mg/5.8mcg, injectable, 1.7 mL glass vial, RX, CreativeNovember 12, 2014
- FDAEPINEPHRINE/WATER, preservative free 1:1000, injectable, 1 mL glass vial, RX, Creative Compounds, Wilsonville,November 12, 2014
- FDAHYDROXYPROGESTERONE CAPROATE (SESAME OIL), 250mg/mL, injectable, 5 mL glass vial, RX, Creative Compounds,November 12, 2014
- FDACHORIONIC GONADOTROPIN, 5000 Units, sterile powder for reconstitution, glass vial, RX, Creative Compounds,November 12, 2014
- FDACALCIUM CHLORIDE (COMPOUND), 100 mg/mL, Injectable, 10 mL glass vial, RX, Creative Compounds, Wilsonville, ORNovember 12, 2014
Questions about this recall
Was CHORIONIC GONADOTROPIN, 4000 Units, sterile powder for reconstitution, glass vial, RX, Creative Compounds, Wilsonville, OR 97070 recalled?
Yes. FDA published recall D-0181-2015 on November 12, 2014. Reported hazard: Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release